Does Incidence of Breast Cancer and Prostate Cancer Decrease with Increasing Degree of Visual Impairment View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-05

AUTHORS

Eero Pukkala, Matti Ojamo, Sirkka-Liisa Rudanko, Richard G. Stevens, Pia K. Verkasalo

ABSTRACT

ObjectiveThe issue of light at night and cancer continuously attracts discussion. The major hypotheses are that melatonin may decrease risk of hormone-related cancers, particularly breast cancer, or even act as a potent antioxidant and thus have a protective effect against cancer development in general.MethodsWe tested the hypothesis that blind persons are at lower risk of cancer in a follow-up study linking a cohort of 17,557 persons with visual impairment identified from the Finnish Register of Visual Impairment with cancer incidence data of the Finnish Cancer Registry for years 1983–2003.ResultsBreast cancer risk in females decreased by degree of visual impairment, and a similar but less consistent trend was observed for prostate cancer in males. The incidence for the remaining cancers among nearly to totally blind persons was significantly higher than in average Finnish population.ConclusionsOur findings add to the suggestive epidemiological evidence for a decreased risk of hormone-related cancers in people with visual impairment and, consequently, a relationship between visible light at night and breast cancer risk. The result is strongly against the hypothesis of a systemic protective effect related lack of visible light. More... »

PAGES

573-576

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10552-005-9005-6

DOI

http://dx.doi.org/10.1007/s10552-005-9005-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044722709

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16596312


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blindness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Light", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vision, Low", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Liisankatu 21B, FIN-00170, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/grid.424339.b", 
          "name": [
            "Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Liisankatu 21B, FIN-00170, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pukkala", 
        "givenName": "Eero", 
        "id": "sg:person.01217520067.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217520067.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Finnish Register of Visual Impairment, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Finnish Register of Visual Impairment, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ojamo", 
        "givenName": "Matti", 
        "id": "sg:person.0602646455.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602646455.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Finnish Register of Visual Impairment, Helsinki, Finland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Finnish Register of Visual Impairment, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rudanko", 
        "givenName": "Sirkka-Liisa", 
        "id": "sg:person.01355747350.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355747350.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Connecticut Health Center, 06030, Farmington, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.208078.5", 
          "name": [
            "University of Connecticut Health Center, 06030, Farmington, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stevens", 
        "givenName": "Richard G.", 
        "id": "sg:person.0626371704.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371704.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Environmental Health, National Public Health Institute, Kuopio, Finland", 
          "id": "http://www.grid.ac/institutes/grid.14758.3f", 
          "name": [
            "Department of Environmental Health, National Public Health Institute, Kuopio, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verkasalo", 
        "givenName": "Pia K.", 
        "id": "sg:person.01072452773.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072452773.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01613283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050024995", 
          "https://doi.org/10.1007/bf01613283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029517050", 
          "https://doi.org/10.1054/bjoc.2000.1617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027171511", 
          "https://doi.org/10.1038/sj.bjc.6690544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1008897317401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033430938", 
          "https://doi.org/10.1023/a:1008897317401"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-05", 
    "datePublishedReg": "2006-05-01", 
    "description": "ObjectiveThe issue of light at night and cancer continuously attracts discussion. The major hypotheses are that melatonin may decrease risk of hormone-related cancers, particularly breast cancer, or even act as a potent antioxidant and thus have a protective effect against cancer development in general.MethodsWe tested the hypothesis that blind persons are at lower risk of cancer in a follow-up study linking a cohort of 17,557 persons with visual impairment identified from the Finnish Register of Visual Impairment with cancer incidence data of the Finnish Cancer Registry for years 1983\u20132003.ResultsBreast cancer risk in females decreased by degree of visual impairment, and a similar but less consistent trend was observed for prostate cancer in males. The incidence for the remaining cancers among nearly to totally blind persons was significantly higher than in average Finnish population.ConclusionsOur findings add to the suggestive epidemiological evidence for a decreased risk of hormone-related cancers in people with visual impairment and, consequently, a relationship between visible light at night and breast cancer risk. The result is strongly against the hypothesis of a systemic protective effect related lack of visible light.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10552-005-9005-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100917", 
        "issn": [
          "0957-5243", 
          "1573-7225"
        ], 
        "name": "Cancer Causes & Control", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "keywords": [
      "hormone-related cancers", 
      "visual impairment", 
      "breast cancer", 
      "protective effect", 
      "cancer risk", 
      "suggestive epidemiological evidence", 
      "prostate cancer decreases", 
      "systemic protective effects", 
      "breast cancer risk", 
      "Finnish Cancer Registry", 
      "cancer incidence data", 
      "Cancer Registry", 
      "decreased risk", 
      "epidemiological evidence", 
      "Finnish Register", 
      "prostate cancer", 
      "lower risk", 
      "cancer decreases", 
      "cancer", 
      "cancer development", 
      "potent antioxidant", 
      "incidence data", 
      "impairment", 
      "ConclusionsOur findings", 
      "Finnish population", 
      "risk", 
      "incidence", 
      "persons", 
      "years 1983", 
      "blind persons", 
      "registry", 
      "cohort", 
      "MethodsWe", 
      "melatonin", 
      "males", 
      "hypothesis", 
      "Register", 
      "antioxidants", 
      "females", 
      "night", 
      "major hypotheses", 
      "effect", 
      "consistent trend", 
      "population", 
      "findings", 
      "evidence", 
      "decrease", 
      "study", 
      "degree", 
      "lack", 
      "people", 
      "data", 
      "development", 
      "relationship", 
      "trends", 
      "results", 
      "light", 
      "discussion", 
      "issues", 
      "visible light"
    ], 
    "name": "Does Incidence of Breast Cancer and Prostate Cancer Decrease with Increasing Degree of Visual Impairment", 
    "pagination": "573-576", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044722709"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10552-005-9005-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16596312"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10552-005-9005-6", 
      "https://app.dimensions.ai/details/publication/pub.1044722709"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_426.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10552-005-9005-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10552-005-9005-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10552-005-9005-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10552-005-9005-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10552-005-9005-6'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      22 PREDICATES      102 URIs      89 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10552-005-9005-6 schema:about N1382ebdc756044e3be6580d749af0dc4
2 N2539d3043cfc42faae20394706a675d3
3 N3d7e56b0f39043a39a87719c5ed68711
4 N635244bd115d441d89d833340fca9c89
5 Nb9b2e9b1e7c24a40810ed3fbf7592741
6 Nc0297addcd5344918311d3c81a7f3c48
7 Ncfce3a37704d4d8eb6ff958b70a075e7
8 Nd4f45d565e6840d7a32bd1b4033c9345
9 Nd5a3deeed1d5405fb76b162a8dd27036
10 Nf5bfb30bb85d44a0b3667a1153e72a3e
11 anzsrc-for:11
12 anzsrc-for:1112
13 anzsrc-for:1117
14 schema:author N03b18af097c44660a4a133722fb3e231
15 schema:citation sg:pub.10.1007/bf01613283
16 sg:pub.10.1023/a:1008897317401
17 sg:pub.10.1038/sj.bjc.6690544
18 sg:pub.10.1054/bjoc.2000.1617
19 schema:datePublished 2006-05
20 schema:datePublishedReg 2006-05-01
21 schema:description ObjectiveThe issue of light at night and cancer continuously attracts discussion. The major hypotheses are that melatonin may decrease risk of hormone-related cancers, particularly breast cancer, or even act as a potent antioxidant and thus have a protective effect against cancer development in general.MethodsWe tested the hypothesis that blind persons are at lower risk of cancer in a follow-up study linking a cohort of 17,557 persons with visual impairment identified from the Finnish Register of Visual Impairment with cancer incidence data of the Finnish Cancer Registry for years 1983–2003.ResultsBreast cancer risk in females decreased by degree of visual impairment, and a similar but less consistent trend was observed for prostate cancer in males. The incidence for the remaining cancers among nearly to totally blind persons was significantly higher than in average Finnish population.ConclusionsOur findings add to the suggestive epidemiological evidence for a decreased risk of hormone-related cancers in people with visual impairment and, consequently, a relationship between visible light at night and breast cancer risk. The result is strongly against the hypothesis of a systemic protective effect related lack of visible light.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N28bd2e66d6a34d2789c60bc94038e1eb
26 N4e892bcb008b47a6bd7074e9e2167d5b
27 sg:journal.1100917
28 schema:keywords Cancer Registry
29 ConclusionsOur findings
30 Finnish Cancer Registry
31 Finnish Register
32 Finnish population
33 MethodsWe
34 Register
35 antioxidants
36 blind persons
37 breast cancer
38 breast cancer risk
39 cancer
40 cancer decreases
41 cancer development
42 cancer incidence data
43 cancer risk
44 cohort
45 consistent trend
46 data
47 decrease
48 decreased risk
49 degree
50 development
51 discussion
52 effect
53 epidemiological evidence
54 evidence
55 females
56 findings
57 hormone-related cancers
58 hypothesis
59 impairment
60 incidence
61 incidence data
62 issues
63 lack
64 light
65 lower risk
66 major hypotheses
67 males
68 melatonin
69 night
70 people
71 persons
72 population
73 potent antioxidant
74 prostate cancer
75 prostate cancer decreases
76 protective effect
77 registry
78 relationship
79 results
80 risk
81 study
82 suggestive epidemiological evidence
83 systemic protective effects
84 trends
85 visible light
86 visual impairment
87 years 1983
88 schema:name Does Incidence of Breast Cancer and Prostate Cancer Decrease with Increasing Degree of Visual Impairment
89 schema:pagination 573-576
90 schema:productId N2f9dc65284574235805624f6978e8bb6
91 N6cee3d1ede9d4fb9ac9d08fcf0c010f1
92 Nd618d25ac8b741628b8fe055e876879c
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044722709
94 https://doi.org/10.1007/s10552-005-9005-6
95 schema:sdDatePublished 2022-06-01T22:06
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher Nc0920b25f44147c891158a9549ca9ea5
98 schema:url https://doi.org/10.1007/s10552-005-9005-6
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N03b18af097c44660a4a133722fb3e231 rdf:first sg:person.01217520067.22
103 rdf:rest Nc448c4a05dbc42e182386338f993b8d9
104 N1382ebdc756044e3be6580d749af0dc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N2539d3043cfc42faae20394706a675d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Prostatic Neoplasms
109 rdf:type schema:DefinedTerm
110 N28bd2e66d6a34d2789c60bc94038e1eb schema:issueNumber 4
111 rdf:type schema:PublicationIssue
112 N2f9dc65284574235805624f6978e8bb6 schema:name doi
113 schema:value 10.1007/s10552-005-9005-6
114 rdf:type schema:PropertyValue
115 N334eb3f1ce3445339688ccc5b6e688ad rdf:first sg:person.0626371704.82
116 rdf:rest Necc2b7bc67da4cc8a9ad7061a78d6ed8
117 N3849382cc5674dc8897cffeec99ce40b rdf:first sg:person.01355747350.16
118 rdf:rest N334eb3f1ce3445339688ccc5b6e688ad
119 N3d7e56b0f39043a39a87719c5ed68711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Incidence
121 rdf:type schema:DefinedTerm
122 N4e892bcb008b47a6bd7074e9e2167d5b schema:volumeNumber 17
123 rdf:type schema:PublicationVolume
124 N635244bd115d441d89d833340fca9c89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Light
126 rdf:type schema:DefinedTerm
127 N6cee3d1ede9d4fb9ac9d08fcf0c010f1 schema:name pubmed_id
128 schema:value 16596312
129 rdf:type schema:PropertyValue
130 Nb9b2e9b1e7c24a40810ed3fbf7592741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Female
132 rdf:type schema:DefinedTerm
133 Nc0297addcd5344918311d3c81a7f3c48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 Nc0920b25f44147c891158a9549ca9ea5 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 Nc448c4a05dbc42e182386338f993b8d9 rdf:first sg:person.0602646455.06
139 rdf:rest N3849382cc5674dc8897cffeec99ce40b
140 Ncfce3a37704d4d8eb6ff958b70a075e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Middle Aged
142 rdf:type schema:DefinedTerm
143 Nd4f45d565e6840d7a32bd1b4033c9345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Vision, Low
145 rdf:type schema:DefinedTerm
146 Nd5a3deeed1d5405fb76b162a8dd27036 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Blindness
148 rdf:type schema:DefinedTerm
149 Nd618d25ac8b741628b8fe055e876879c schema:name dimensions_id
150 schema:value pub.1044722709
151 rdf:type schema:PropertyValue
152 Necc2b7bc67da4cc8a9ad7061a78d6ed8 rdf:first sg:person.01072452773.36
153 rdf:rest rdf:nil
154 Nf5bfb30bb85d44a0b3667a1153e72a3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Breast Neoplasms
156 rdf:type schema:DefinedTerm
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
161 schema:name Oncology and Carcinogenesis
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
164 schema:name Public Health and Health Services
165 rdf:type schema:DefinedTerm
166 sg:journal.1100917 schema:issn 0957-5243
167 1573-7225
168 schema:name Cancer Causes & Control
169 schema:publisher Springer Nature
170 rdf:type schema:Periodical
171 sg:person.01072452773.36 schema:affiliation grid-institutes:grid.14758.3f
172 schema:familyName Verkasalo
173 schema:givenName Pia K.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072452773.36
175 rdf:type schema:Person
176 sg:person.01217520067.22 schema:affiliation grid-institutes:grid.424339.b
177 schema:familyName Pukkala
178 schema:givenName Eero
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217520067.22
180 rdf:type schema:Person
181 sg:person.01355747350.16 schema:affiliation grid-institutes:None
182 schema:familyName Rudanko
183 schema:givenName Sirkka-Liisa
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355747350.16
185 rdf:type schema:Person
186 sg:person.0602646455.06 schema:affiliation grid-institutes:None
187 schema:familyName Ojamo
188 schema:givenName Matti
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602646455.06
190 rdf:type schema:Person
191 sg:person.0626371704.82 schema:affiliation grid-institutes:grid.208078.5
192 schema:familyName Stevens
193 schema:givenName Richard G.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626371704.82
195 rdf:type schema:Person
196 sg:pub.10.1007/bf01613283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050024995
197 https://doi.org/10.1007/bf01613283
198 rdf:type schema:CreativeWork
199 sg:pub.10.1023/a:1008897317401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033430938
200 https://doi.org/10.1023/a:1008897317401
201 rdf:type schema:CreativeWork
202 sg:pub.10.1038/sj.bjc.6690544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027171511
203 https://doi.org/10.1038/sj.bjc.6690544
204 rdf:type schema:CreativeWork
205 sg:pub.10.1054/bjoc.2000.1617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029517050
206 https://doi.org/10.1054/bjoc.2000.1617
207 rdf:type schema:CreativeWork
208 grid-institutes:None schema:alternateName Finnish Register of Visual Impairment, Helsinki, Finland
209 schema:name Finnish Register of Visual Impairment, Helsinki, Finland
210 rdf:type schema:Organization
211 grid-institutes:grid.14758.3f schema:alternateName Department of Environmental Health, National Public Health Institute, Kuopio, Finland
212 schema:name Department of Environmental Health, National Public Health Institute, Kuopio, Finland
213 rdf:type schema:Organization
214 grid-institutes:grid.208078.5 schema:alternateName University of Connecticut Health Center, 06030, Farmington, CT, USA
215 schema:name University of Connecticut Health Center, 06030, Farmington, CT, USA
216 rdf:type schema:Organization
217 grid-institutes:grid.424339.b schema:alternateName Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Liisankatu 21B, FIN-00170, Helsinki, Finland
218 schema:name Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Liisankatu 21B, FIN-00170, Helsinki, Finland
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...